Dr. Agarwal's Q1 FY27 earnings call transcript filed

Mgmt Guided Margin ImprovementOrder Pipeline DisclosedCfo Debt Reduction RoadmapInvestor Communications View source PDF Explain this filing

AGARWALEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.7%1-day move

₹547.50

prior close

₹546.25

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.4+1.7+1.7+2.7-0.7-6.7-7.7-7.5-8.9-9.0————

Up moveDown movePending

AI summary

Q1 FY27 results: revenue from operations INR614 cr (up 26% YoY, 8.8% sequential), EBITDA INR177 cr at 28.5% margin (up 25% YoY), PAT margin 8.9% (up 127 bps). Launched 18 greenfield facilities including 16 surgical, a record. SSSG 16.3% for mature facilities. North region revenue up 50.5% YoY. Served over 8.8 lakh patients, performed 91,000 surgeries (15.5% YoY). Greenfield losses at about INR20 cr. Plans to add 60 facilities in FY27 with 30-plus signed LOIs. Merger expected to close by mid-November.

Likely market impact

Strong Q1 with 26% revenue growth, margin expansion and record facility additions signals healthy momentum; merger closure expected by mid-November.